- Confirm the event meets the definition of a TIA: a transient episode of neurologic dysfunction caused by focal brain, spinal cord, or retinal ischemia, without acute infarction on imaging.
- Score each of the five items: Age, Blood pressure at first evaluation, Clinical features, Duration of symptoms, and Diabetes. The total and risk band update automatically.
- Read the stratified 2-day, 7-day, and 90-day stroke-risk estimates alongside the clinical story, vascular imaging, and cardiac work-up — do not use the total alone to decide admission or discharge.
- Admit or arrange urgent same-day outpatient evaluation per current AHA/ASA guidance; most patients with a confirmed TIA benefit from expedited imaging and secondary-prevention review whatever the ABCD² score.
All computation runs in your browser; no values are stored or transmitted.
When to Use
Use the ABCD² score in the first evaluation of a patient after a suspected transient ischemic attack (TIA), to describe early-stroke risk and prioritise the speed of work-up. The score was derived and validated in large cohorts to predict 2-day, 7-day, and 90-day stroke after TIA; it is best used alongside vascular imaging (carotid duplex or CT angiography), cardiac rhythm monitoring, and brain imaging rather than as a standalone admission rule.
Appropriate population
Adults presenting after a transient focal neurologic deficit consistent with TIA, where a secondary-prevention pathway (vascular imaging, cardiac monitoring, statin and antithrombotic review) is being planned. Also useful for communicating urgency to receiving teams and families.
When NOT to rely on it alone
ABCD² does not identify the cause of the TIA, does not rule out a high-risk carotid or cardiac source in low-scoring patients, and is not sensitive to patients with crescendo TIAs or persistent diffusion-weighted imaging changes. Contemporary AHA/ASA guidance favors admission or an expedited same-day outpatient pathway for all suspected TIAs — ABCD² alone should not drive admit-versus-discharge, and low scores never exclude a treatable large-vessel lesion.
Pearls & Pitfalls
Use the FIRST blood pressure
Score the initial blood pressure at presentation, not a later value after treatment. The derivation cohort used the first recorded reading, and a treated normotensive reading underscores an at-risk patient. "Weakness" scores two points only when the deficit is unilateral motor weakness; speech disturbance without weakness scores one; any other symptom (sensory alone, dizziness alone) scores zero.
Pair with imaging — always
A low ABCD² does not exclude a high-grade carotid stenosis or intracranial large-vessel lesion. Obtain urgent carotid imaging and consider an MRI with diffusion sequences in every TIA pathway; a positive DWI makes the event a "tissue-defined" stroke rather than a TIA and changes management.
Pitfalls
(1) Dizziness, isolated vertigo, or confusion alone do not usually count as "weakness" or "speech disturbance" — do not inflate the clinical-features item. (2) Durations are mutually exclusive — do not double-count a long event. (3) The Wardlaw 2015 meta-analysis showed that routine use of ABCD² to decide admission missed important fractions of early strokes; use it to communicate urgency, not to filter who gets a work-up. (4) The score is weaker in young patients, in patients with crescendo TIAs, and in known atrial fibrillation — anticoagulation decisions should not depend on ABCD².
Why Use It
The ABCD² score is a simple, memorable bedside tool that quantifies early-stroke risk after a TIA. Two-day stroke rates rise from about 1% in low-scoring patients to about 8% in high-scoring patients, and a high score reliably escalates the perceived urgency of vascular imaging, cardiac monitoring, antiplatelet start, blood-pressure management, and statin initiation. It is understood by emergency teams, admitting services, and neurology consultants, and it provides defensible documentation of why a given TIA was treated as "high risk." The score is complementary to — not a substitute for — a structured TIA work-up.
ABCD² Score for TIA
Score each of the five items. The total (0–7) and stratified 2-day, 7-day, and 90-day stroke-risk estimates update automatically.
⚕ Johnston SC et al. Lancet. 2007;369(9558):283–292. ABCD² estimates post-TIA stroke risk; it does not establish the TIA's cause, does not substitute for vascular or cardiac imaging, and should not be used on its own to decide admission or discharge. For licensed clinicians; integrate with imaging, cardiac work-up, and current AHA/ASA guidance.
Next Steps
Treat the ABCD² total as a framing device for urgency, not a discharge rule.
- Total 0–3 (low risk): 2-day stroke risk about 1.0%, 7-day about 1.2%, 90-day about 3.1%. Still complete an expedited same-day or next-day TIA pathway: brain imaging (MRI with DWI preferred), carotid imaging, ECG, consider prolonged rhythm monitoring, start or optimize antiplatelet and statin, control blood pressure.
- Total 4–5 (moderate risk): 2-day stroke risk about 4.1%, 7-day about 5.9%, 90-day about 9.8%. Admission or a high-acuity same-day observation pathway is reasonable. Confirm large-vessel vasculature and cardiac rhythm; start dual antiplatelet therapy (aspirin + clopidogrel) where guideline criteria are met, and control blood pressure.
- Total 6–7 (high risk): 2-day stroke risk about 8.1%, 7-day about 11.7%, 90-day about 17.8%. Admit for close observation and rapid vascular and cardiac work-up. Consider early dual antiplatelet therapy (per CHANCE / POINT trial eligibility) and urgent carotid intervention if a high-grade symptomatic stenosis is found.
- For any score, document the NIHSS if a deficit is still present on arrival, and if imaging reveals intracerebral hemorrhage, use the ICH Score for severity grading.
Evidence & References
Scoring
| Item | Points |
|---|---|
| Age ≥ 60 years | +1 |
| Blood pressure ≥ 140/90 mm Hg at first evaluation | +1 |
| Clinical features — unilateral weakness | +2 |
| Clinical features — speech disturbance without weakness | +1 |
| Clinical features — other symptoms | 0 |
| Duration ≥ 60 minutes | +2 |
| Duration 10–59 minutes | +1 |
| Duration < 10 minutes | 0 |
| Diabetes mellitus | +1 |
| Total | 0–7 |
Stroke risk bands (Johnston 2007 derivation cohort)
| Total | Band | 2-day | 7-day | 90-day |
|---|---|---|---|---|
| 0–3 | Low | 1.0% | 1.2% | 3.1% |
| 4–5 | Moderate | 4.1% | 5.9% | 9.8% |
| 6–7 | High | 8.1% | 11.7% | 17.8% |
The ABCD² score was derived from pooled data of four TIA cohorts and refined to improve prediction of 2-day stroke. The Wardlaw meta-analysis later showed that routine use of ABCD² alone to admit or discharge TIA patients missed meaningful fractions of early strokes, so current practice pairs ABCD² with a structured TIA work-up and treats all suspected TIAs as time-sensitive.
References
- Johnston, S. C., Rothwell, P. M., Nguyen-Huynh, M. N., Giles, M. F., Elkins, J. S., Bernstein, A. L., & Sidney, S. (2007). Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet, 369(9558), 283–292. doi:10.1016/S0140-6736(07)60150-0.
- Wardlaw, J. M., Brazzelli, M., Chappell, F. M., Miranda, H., Shuler, K., Sandercock, P. A. G., & Dennis, M. S. (2015). ABCD2 score and secondary stroke prevention: Meta-analysis and effect per 1,000 patients triaged. Neurology, 85(4), 373–380. doi:10.1212/WNL.0000000000001780.
